Credential Qtrade Securities Inc. Genmab A/S Transaction History

Credential Qtrade Securities Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 21, 2025	SELL	$20.05 - $33.89 $18,847 - $31,856	-940 Closed	0 $0
Q1 2020 Jul 21, 2025	BUY	$17.15 - $25.22 $7,631 - $11,222	445 Added 89.9%	940 $19.9 Million
Q4 2019 Jul 21, 2025	BUY	$18.88 - $24.14 $2,190 - $2,800	116 Added 30.61%	495 $11.1 Million
Q3 2019 Jul 21, 2025	BUY	$18.0 - $21.38 $6,822 - $8,103	379 New	379 $7.68 Million

254

65.2M

32.5K

55K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $18.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.